The expanding role of somatostatin analogues in the treatment of neuroendocrine tumours: the CLARINET study

被引：9
作者：
Kaltsas, Gregory [1 ]
Grossman, Ashley B. [2 ]
机构：
[1] Natl Tech Univ Athens, Dept Pathophysiol, Athens 11527, Greece
[2] Univ Oxford, Churchill Hosp, Oxford Ctr Diabet Endocrinol & Metab, Oxford, England
来源：
CLINICAL ENDOCRINOLOGY | 2015年 / 83卷 / 06期
关键词：
PROGNOSTIC-FACTORS; RECEPTOR BIOLOGY; EXPRESSION; SCINTIGRAPHY; MANAGEMENT; EVEROLIMUS; UPDATE;
D O I：
10.1111/cen.12831
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：759 / 761
页数：3
相关论文
共 50 条
[21]   Role of biological targeted therapies in gastroenteropancreatic neuroendocrine tumours [J].
Yim, Kein-Leong .
ENDOCRINE, 2011, 40 (02) :181-186
[22]   Radiolabelled somatostatin analogue treatment in gastroenteropancreatic neuroendocrine tumours: factors associated with response and suggestions for therapeutic sequence [J].
Campana, Davide ;
Capurso, Gabriele ;
Partelli, Stefano ;
Nori, Francesca ;
Panzuto, Francesco ;
Tamburrino, Domenico ;
Cacciari, Giulia ;
Delle Fave, Gianfranco ;
Falconi, Massimo ;
Tomassetti, Paola .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 40 (08) :1197-1205
[23]   Results of treatment for thymic neuroendocrine tumours: multicentre clinicopathological study [J].
Ose, Naoko ;
Maeda, Hajime ;
Inoue, Masayoshi ;
Morii, Eiichi ;
Shintani, Yasushi ;
Matsui, Hiroshi ;
Tada, Hirohito ;
Tokunaga, Tositeru ;
Kimura, Kenji ;
Sakamaki, Yasushi ;
Takeuchi, Yukiyasu ;
Fukuhara, Kenjiro ;
Katsura, Hiroshi ;
Iwasaki, Teruo ;
Okumura, Andmeinoshin .
INTERACTIVE CARDIOVASCULAR AND THORACIC SURGERY, 2018, 26 (01) :18-24
[24]   Efficacy and safety of high-dose lanreotide autogel in patients with progressive pancreatic or midgut neuroendocrine tumours: CLARINET FORTE phase 2 study results [J].
Pavel, Marianne ;
Cwikla, Jaroslaw B. ;
Lombard-Bohas, Catherine ;
Borbath, Ivan ;
Shah, Tahir ;
Pape, Ulrich F. ;
Capdevila, Jaume ;
Panzuto, Francesco ;
Thanh, Xuan-Mai Truong ;
Houchard, Aude ;
Ruszniewski, Philippe .
EUROPEAN JOURNAL OF CANCER, 2021, 157 :403-414
[25]   Efficacy and Safety of Everolimus plus Somatostatin Analogues in Patients with Neuroendocrine Tumors [J].
Ge, Wenhao ;
Zhou, Dongkai ;
Zhu, Lijun ;
Song, Wei ;
Wang, Weilin .
JOURNAL OF CANCER, 2018, 9 (24) :4783-4790
[26]   Efficacy and tolerability of somatostatin analogues according to gender in patients with neuroendocrine tumors [J].
Ruggeri, Rosaria M. ;
Aini, Irene ;
Gay, Stefano ;
Grossrubatscher, Erika Maria ;
Mancini, Camilla ;
Tarsitano, Maria Grazia ;
Zamponi, Virginia ;
Isidori, Andrea M. ;
Colao, Annamaria ;
Faggiano, Antongiulio .
REVIEWS IN ENDOCRINE & METABOLIC DISORDERS, 2024, 25 (02) :383-398
[27]   Comparing Somatostatin Analogs in the Treatment of Advanced Gastroenteropancreatic Neuroendocrine Tumors [J].
Allaw, Mohammed B. ;
Switchenko, Jeffrey M. ;
Khalil, Lana ;
Wu, Christina ;
Alese, Olatunji B. ;
Akce, Mehmet ;
Draper, Amber ;
Jones, Aaron T. ;
El-Rayes, Bassel ;
Shaib, Walid .
ONCOLOGY, 2022, :131-139
[28]   Diagnosis and treatment options of neuroendocrine tumours [J].
Uhlyarik Andrea ;
Papai Zsuzsanna .
ORVOSI HETILAP, 2013, 154 (39) :1549-1555
[29]   Role of Somatostatin Receptor in Pancreatic Neuroendocrine Tumor Development, Diagnosis, and Therapy [J].
Hu, Yuheng ;
Ye, Zeng ;
Wang, Fei ;
Qin, Yi ;
Xu, Xiaowu ;
Yu, Xianjun ;
Ji, Shunrong .
FRONTIERS IN ENDOCRINOLOGY, 2021, 12
[30]   Treatment of Unresectable Intracranial Meningiomas with Somatostatin Analogues [J].
Schulz, C. ;
Mathieu, R. ;
Kunz, U. .
AKTUELLE NEUROLOGIE, 2010, 37 (04) :178-182
12345